SO
FATE icon

STRS Ohio’s Fate Therapeutics FATE Stock Holding History

STRS Ohio’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-500
Closed -$12K – 2028
2022
Q2 		$12K Sell
500
-8,000
-94% -$221K ﹤0.01% 1988
2022
Q1 		$329K Sell
8,500
-4,000
-32% -$155K ﹤0.01% 1573
2021
Q4 		$731K Sell
12,500
-5,300
-30% -$300K ﹤0.01% 1331
2021
Q3 		$1.05M Hold
17,800
– – ﹤0.01% 1069
2021
Q2 		$1.54M Buy
17,800
+2,000
+13% +$161K 0.01% 885
2021
Q1 		$1.3M Buy
15,800
+4,800
+44% +$460K ﹤0.01% 990
2020
Q4 		$1M Buy
11,000
+5,800
+112% +$360K ﹤0.01% 1059
2020
Q3 		$207K Buy
5,200
+2,500
+93% +$87.3K ﹤0.01% 1657
2020
Q2 		$92K Buy
+2,700
New +$80.5K ﹤0.01% 1808
2020
Q1 		– Sell
-80,000
Closed -$1.56M – 2044
2019
Q4 		$1.56M Hold
80,000
– – 0.01% 712
2019
Q3 		$1.24M Hold
80,000
– – 0.01% 742
2019
Q2 		$1.62M Hold
80,000
– – 0.01% 687
2019
Q1 		$1.41M Hold
80,000
– – 0.01% 726
2018
Q4 		$1.03M Sell
80,000
-1,200
-1% -$16.7K 0.01% 775
2018
Q3 		$1.32M Hold
81,200
– – 0.01% 763
2018
Q2 		$920K Buy
81,200
+70,100
+632% +$772K ﹤0.01% 938
2018
Q1 		$108K Hold
11,100
– – ﹤0.01% 1588
2017
Q4 		$67K Hold
11,100
– – ﹤0.01% 1697
2017
Q3 		$43K Hold
11,100
– – ﹤0.01% 1805
2017
Q2 		$35K Buy
+11,100
New +$42.5K ﹤0.01% 1843

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

STRS Ohio's FATE Position: Q3 2022 in Review

STRS Ohio sold out of Fate Therapeutics (FATE) in Q3 2022, closing a stake of 500 shares — an estimated $12K sold.

STRS Ohio first reported a position in FATE in Q2 2017 and held it in 20 quarters. The position peaked at $1.62M in Q2 2019. 239 funds tracked by Wall St. Rank hold FATE as of Q3 2022.

  • STRS Ohio reported no remaining Fate Therapeutics position as of Q3 2022 after selling out during the quarter.
  • STRS Ohio sold 500 Fate Therapeutics shares in Q3 2022, an estimated $12K.
  • STRS Ohio first reported a position in Fate Therapeutics in Q2 2017 and held it in 20 quarters.
  • STRS Ohio's Fate Therapeutics position peaked at $1.62M in Q2 2019.
  • 239 funds tracked by Wall St. Rank held Fate Therapeutics as of Q3 2022.

Based on STRS Ohio's 13F filing for Q3 2022, filed 27 Oct 2022.